Results 101 to 110 of about 30,448 (236)

Effect of Several Factors on Total and Differential Counting of Somatic Cells in Farm Bulk Tank Milk

open access: yesJournal of Food Protection, 1978
Samples from approximately 1000 bulk tanks from widely separated areas of Ontario were examined over a period of 1 year. Total and differential somatic cell content was estimated electronically. A high degree of reproducibility was shown both in total cell count, and percent of cell volume in specific size ranges (channels) determined with a Coulter ...
openaire   +2 more sources

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Cut‐off value of somatic cell count and validation of differential somatic cell count by the fluoro‐optical method in subclinical mastitis milk in three sheep breeds

open access: yesInternational Journal of Dairy Technology
Somatic cell count (SCC) is a test used for mastitis control in ewes, but there is no consensus on the cut‐off value. Other markers of subclinical mastitis (SCM) have been proposed as potentially more efficient, sensitive and specific, such as differential somatic cell count (DSCC).
Marco Montagnani   +10 more
openaire   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Composition, indigenous proteolytic enzymes and coagulating behaviour of ewe milk as affected by somatic cell count

open access: yes, 2011
This study was undertaken to assess the effect of somatic cell count in ewe milk on i) composition and hygienic traits; ii) plasmin, cathepsin and elastase activities; iii) leukocyte differential count; iv) renneting parameters.
Agostino Sevi   +5 more
core   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

open access: yesMolecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski   +12 more
wiley   +1 more source

Use of somatic cell count, differential somatic cell count and mid-infrared spectra for the prediction of mastitis based on bacteriological tests

open access: yes, 2023
Mastitis, eine Entzündung des Eutergewebes, ist eine sehr häufige Erkrankung von Milchkühen, die wirtschaftliche Verluste verursacht und das Wohlbefinden der Tiere stark beeinträchtigt. Eine Reihe von meist bakteriellen Erregern verursachen Mastitis.
Moser, Johannes
core   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy